(Q34270992)

1 August 2017

1 reference

title

Parkinson's disease and other alpha-synucleinopathies (English)

1 reference

1 August 2017

1 reference

M Goedert

1

1 reference

1 August 2017

publication date

1 April 2001

1 reference

Clinical Chemistry and Laboratory Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

308-312

1 reference

Lewy bodies in cerebral cortex, report of three cases

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Multiple-system atrophy: a new alpha-synuclein disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Identification of two distinct synucleins from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Persyn, a member of the synuclein family, influences neurofilament network integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

Comparative genomics of the eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.047

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.047

1 reference

1 August 2017

1 reference